Dr. Kieran McQuinn:

On the corporation tax take, a consistent theme of what we have been saying in recent commentary, and going back to the earlier contributions, is the issue of concentration risk. That shows up on the corporation tax side in terms of the huge contributions to the corporation tax take from certain key sectors of the multinational part of the economy, in particular ICT and pharma. To the extent that any of these financial sector issues could have adverse outcomes for those sectors, then that would be a way in which the corporation tax take could be impacted. On the ICT side, Dr. O'Toole might have something to say about the SVB issue, where there may be some knock-on effects.